Welcome to LookChem.com Sign In|Join Free
The company logo of Hangzhou ZeErRui Chemical Co., Ltd.

Hangzhou ZeErRui Chemical Co., Ltd.

Assessed Supplier

Assessed
Supplier
8th
years

Hangzhou ZeErRui Chemical Co., Ltd.

Business Type:Lab/Research institutions

Main Products:
Pharmaceutical raw materials and intermediates&Pesticide raw materials and intermediates&Fine chemicals&Abiochemical product
Year Established:
2017
Home>>Products>>methyl 2,2-difluorobenzo[d][1,3]dioxole-5-carboxylate

Product Certification&
Enterprise Certification

More Detail

Hangzhou ZeErRui Chemical Co., Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Ms.Pan

Tel: +86-571-82512721

Mobile: 8615067157489

Tel: +86-571-82512721

Fax: +86-571-57153510

URL: http://www.chinazerchem.com

Province/state: Zhejiang Province

City: Hangzhou City

Street: No 317,Jingling Road,Guali Town,Xiaoshan District

MaxCard:


qq Contact Suppliers

methyl 2,2-difluorobenzo[d][1,3]dioxole-5-carboxylate

CAS NO.773873-95-3

  • Min.Order: 0
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • methyl 2,2-difluoro-2H-1,3-benzodioxole-5-carboxylate

Quick Details

  • ProName: methyl 2,2-difluorobenzo[d][1,3]dioxol...
  • CasNo: 773873-95-3
  • Appearance: Based on COA
  • Application: Chemical raw materials
  • DeliveryTime: Stock
  • PackAge: 25KG/durm
  • Port: Shanghai
  • Purity: 98%
  • Storage: Sealed and preserved
  • Transportation: By sea/By air/By courier
  • LimitNum: 0

Superiority

Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.

Details